Mason987 · Newsroom

More than 100 industry players and over 60 non-industry players currently claim to manufacture different types of cell therapies.
Owing to various reasons, the demand for cell therapies is anticipated to increase over the coming years. Therefore, both therapy developers and contract service providers may need to strengthen

April 16, 2021

The cell therapy manufacturing market is estimated to reach close to USD 11 Billion by 2030
Manufacturing cell therapies is technically and financially demanding; as a result, despite therapy developers gradually strengthening their in-house expertise

April 16, 2021

Growing at an annualized rate of over 16.5%,
Owing to various reasons, the demand for cell therapies is anticipated to increase over the coming years. Therefore, both therapy developers and contract service providers may need to strengthen their capabilities and expand available capacity

April 16, 2021

‘Patient Recruitment and Retention Services, 2019-2030’
detailed assessment of the current market landscape of companies offering patient recruitment and retention services, including information on over 10 types of patient outreach methods employed

April 16, 2021

Presently, close to 140 companies claim to be actively engaged in offering patient recruitment
A steadily increasing demand for study participants and the complexities associated with patient enrollment has imposed a significant burden on drug developer companies

April 16, 2021

Patient recruitment and retention services market is projected to grow at an annualized rate of ~5%,
Roots Analysis has done a detailed study on Patient Recruitment and Retention Services Marker, 2019-2030.”, covering key aspects of the industry’s evolution and identifying potential future growth opportunities.

April 16, 2021

Patient recruitment and retention services market is estimated to be worth USD 5.3 billion in 2030,
A steadily increasing demand for participants in clinical research studies, coupled to the complexities associated with patient enrolment

April 16, 2021

“Next Generation Immune Checkpoint Inhibitors and Stimulators Market, 2020-2030”
A detailed assessment of the current market landscape, including information on drug developer(s), phase of development

April 9, 2021

The potential of nearly 300 next generation immune checkpoint modulators for the treatment (Roots Analysis)
Over time, significant strides have been made in immune checkpoint research, resulting in the discovery of several inhibitory

April 9, 2021

Inhibitors and stimulators market is projected to grow at an annualized rate of ~15% (till 2030)
Roots Analysis has done a detailed study on Next Generation Immune Checkpoint Inhibitors and Stimulators Market, 2020-2030.

April 9, 2021

The next generation immune checkpoint inhibitors and stimulators market (Roots Analysis)
Therapies targeting novel inhibitory and stimulatory immune checkpoints have been shown to possess substantial therapeutic potential

April 9, 2021

“Endocannabinoid System Targeted Therapeutics Market, 2020-2030”
A detailed assessment of the current market landscape of endocannabinoid system targeted therapeutics, providing information on phase of development

April 9, 2021

Presently engaged in evaluating the clinical applications of over 180 cannabinoid-derivatives
Over time, extensive R&D on the potential health benefits of cannabis, have enabled medical researchers to identify a number of pharmacologically

April 9, 2021

The endocannabinoid system is projected to grow at an annualized rate of ~30%, (till 2030)
Roots Analysis has done a detailed study on Endocannabinoid System Targeted Therapeutics Market, 2020-2030 “

April 9, 2021

The endocannabinoid system targeted therapeutics market < Roots Analysis>
So far, more than 100 different cannabinoids have been identified, and there is a growing body of evidence supporting

April 9, 2021

Endocannabinoid system targeted therapeutics market is growing at an annualized rate of 30%, (Roots Analysis)
So far, more than 100 different types of cannabinoids have been identified and there is a growing body of evidence

April 9, 2021